simvastatin has been researched along with Peripheral Vascular Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armitage, J; Chen, F; Chen, YP; Chen, ZM; Feng, F; Gao, Y; Hopewell, JC; Hundei, WB; Jiang, LX; Landray, M; Li, J; Li, X; Liu, JM; Valdes-Marquez, E; Zhang, D; Zhang, HB | 1 |
| Ahn, C; Aronow, WS | 1 |
| Conroy, C; Robinson, JG; Wickemeyer, WJ | 1 |
| Agricola, E; Ammaturo, T; Ballo, P; Barbati, R; Belcastro, M; Borrello, F; Guerrini, F; Mondillo, S; Nami, R; Pastore, M; Picchi, A | 1 |
| Ahn, C; Aronow, WS; Nayak, D; Woodworth, S | 1 |
| Mascitelli, L; Rose, CP; Vos, E | 1 |
| Kroon, AA; Stalenhoef, AF; van Asten, WN | 1 |
| Allen, SE; Attanasio, E; Russo, P | 1 |
5 trial(s) available for simvastatin and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease.
Topics: Aged; Anticholesteremic Agents; Blood Pressure Determination; Double-Blind Method; Female; Humans; Hypercholesterolemia; Intermittent Claudication; Male; Peripheral Vascular Diseases; Simvastatin; Walking | 2003 |
Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment.
Topics: Aged; Aged, 80 and over; Exercise Test; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intermittent Claudication; Male; Middle Aged; Outcome Assessment, Health Care; Peripheral Vascular Diseases; Severity of Illness Index; Simvastatin; Time Factors | 2003 |
Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions.
Topics: Aged; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Patient Compliance; Peripheral Vascular Diseases; Practice Guidelines as Topic; Risk Assessment; Simvastatin; Treatment Outcome; United Kingdom | 2007 |
Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Component Removal; Cholesterol, LDL; Combined Modality Therapy; Coronary Artery Disease; Disease Progression; Enzyme Inhibitors; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Peripheral Vascular Diseases; Simvastatin | 1996 |
Cost-minimization analysis of simvastatin versus atorvastatin for maintenance therapy in patients with coronary or peripheral vascular disease.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Coronary Disease; Cost Control; Drug Costs; Europe; Heptanoic Acids; Humans; Hypercholesterolemia; Peripheral Vascular Diseases; Pyrroles; Simvastatin | 2001 |
4 other study(ies) available for simvastatin and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Atorvastatin; Cerebrovascular Disorders; Coronary Artery Disease; Cross-Sectional Studies; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Peripheral Vascular Diseases; Pyrroles; Secondary Prevention; Simvastatin | 2012 |
Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Female; Follow-Up Studies; Health Services for the Aged; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Myocardial Infarction; New York; Peripheral Vascular Diseases; Pravastatin; Prospective Studies; Simvastatin; Treatment Outcome; Triglycerides | 2002 |
Comparison of effectiveness and safety of simvastatin in patients <75 versus > or =75 years of age with coronary, cerebral, or peripheral arterial disease.
Topics: Age Factors; Aged; Cerebral Arterial Diseases; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Middle Aged; Peripheral Vascular Diseases; Retrospective Studies; Risk Factors; Safety; Simvastatin; Survival Analysis; Treatment Outcome | 2002 |
Regarding "does simvastatin save lives; If so, when and in whom?".
Topics: Anticholesteremic Agents; Female; Humans; Male; Peripheral Vascular Diseases; Sex Factors; Simvastatin | 2008 |